Dr. Colleen M Culley is a pharmacist who is specialized in Pharmacotherapy in Pittsburgh, Pennsylvania. Patients can reach her at 200 Lothrop St, 302 Scaife Hall, Pittsburgh or contact her on 412-647-1713. Active license number of Dr. Colleen M Culley is RP045818R for Pharmacotherapy in Pennsylvania. Dr. Colleen M Culley is a licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing pharmacotherapeutic care of patients, by developing, implementing, monitoring, and modifying complex treatment plans, providing advanced level education and consultation, and collaborating with other health professionals in the management of therapy.
Complete Profile:
Dr. Colleen M Culley speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Dr. Colleen M Culley are as mentioned below.
NPI Number:
1699802157
NPI Enumeration Date:
28 Feb, 2007
NPI Last Update On:
08 Jul, 2007
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Dr. Colleen M Culley are as mentioned below.
Specialization
License Number
State
Status
Pharmacotherapy
RP045818R
Pennsylvania
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
165 Crossing Ridge Trl, Cranberry Township, Pennsylvania
Zip:
16066-6515
Phone Number:
--
Fax Number:
--
Patients can reach Dr. Colleen M Culley at 200 Lothrop St, 302 Scaife Hall, Pittsburgh, Pennsylvania or can call on phone at 412-647-1713.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.